Search

Your search keyword '"International Business Machines Corp. -- Product development"' showing total 6,363 results

Search Constraints

Start Over You searched for: Descriptor "International Business Machines Corp. -- Product development" Remove constraint Descriptor: "International Business Machines Corp. -- Product development"
6,363 results on '"International Business Machines Corp. -- Product development"'

Search Results

1. The day is fast approaching when we will be unable to keep any data safe from criminals. Quantum computers being developed will have power to crack almost every code in the world very quickly

2. International Business Machines Corporation (IBM) Reports Findings in Boltzmann Machines (Solving Max-Cut Problem Using Spiking Boltzmann Machine Based on Neuromorphic Hardware with Phase Change Memory)

3. Abcuro Completed Enrollment of Registrational Phase 2|3 MUSCLE Clinical Trial of Ulviprubart for the Treatment of Inclusion Body Myositis

4. Abcuro Completes Enrollment of Registrational Phase 2/3 MUSCLE Clinical Trial of Ulviprubart for the Treatment of Inclusion Body Myositis

5. Effect of cognitive - behavioral play therapy on working memory, short-term memory and sustained attention among school-aged children with specific learning disorder: a preliminary randomized controlled clinical trial

6. Abcuro Initiates Part B of Registrational Phase 2|3 MUSCLE Clinical Trial of Ulviprubart (ABC008) for the Treatment of Inclusion Body Myositis

7. Abcuro Initiates Part B of Registrational Phase 2/3 MUSCLE Clinical Trial of Ulviprubart (ABC008) for the Treatment of Inclusion Body Myositis

8. Siemens and IBM collaborate to accelerate sustainable product development and operations

9. United States : Siemens and IBM collaborate to accelerate sustainable product development and operations

10. Siemens and IBM collaborate to accelerate sustainable product development and operations

11. Siemens and IBM collaborate to accelerate sustainable product development and operations

12. Abcuro Initiated Registrational Phase 2|3 Study of ABC008 for the Treatment of Inclusion Body Myositis

13. Abcuro Initiates Registrational Phase 2/3 Study of ABC008 for the Treatment of Inclusion Body Myositis

14. New Data from University of North Carolina Illuminate Findings in Clinical Trials and Studies [A Randomized Trial Comparing Continence Pessary To Continence Device (Poise Impressa ®) for Stress Incontinence]

15. Abcuro Initiates Registrational Phase 2/3 Study of ABC008 for the Treatment of Inclusion Body Myositis

16. Abcuro Initiates Phase 1/2 Trial Evaluating ABC008 in Patients with T Cell Large Granular Lymphocytic Leukemia

17. Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

18. Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

19. Valued to be $3.9 Billion by 2026, Phase Change Memory Slated for Robust Growth Worldwide

20. Global Phase Change Memory Market to Reach $4 Billion by 2026

21. Health Quest to boost participation in clinical trials with IBM Watson

22. McCormick & Co. teams up with IBM in AI-enabled product development

23. IBM says new ultradense microchip might one day quadruple your cellphone's battery life

24. Abcuro to Presented Late-Breaking Abstract at American College of Rheumatology Convergence 2021 of ABC008 Inclusion Body Myositis Phase 1 Data Demonstrating Proof of Mechanism for Selective Depletion of Highly Cytotoxic T Cells

25. Abcuro to Present Late-Breaking Abstract at American College of Rheumatology Convergence 2021 of ABC008 Inclusion Body Myositis Phase 1 Data Demonstrating Proof of Mechanism for Selective Depletion of Highly Cytotoxic T Cells

26. Monopar Announces First Patient Dose in Camsirubicin Phase 1b Trial for Advanced Soft Tissue Sarcoma

27. Abcuro to Present Trial in Progress Poster on a Phase 1 Clinical Trial of ABC008 Demonstrating Targeted Depletion of Large Granular Lymphocytes at the 2021 Leukemia, Lymphoma and Myeloma Congress

28. WATSON LEARNS TO DEBATE: IBM Watson is a computer system that can answer questions posed to it in natural language. It might be most famous for its defeat of the two Jeopardy! champions in 2011, but the number of Watson's commercial applications from 2013 has grown into a division (IBM Watson products and solutions) at the company

29. Airtel and IBM complete first phase of Open Hybrid Cloud Network

30. Jazz and the eclipse way of collaboration

31. Patterning the world

32. Sanofi-backed Abcuro bags $42M to trial KLRG1 immunotherapy

33. Sanofi-backed Abcuro bags $42M to trial KLRG1 immunotherapy

34. The Open Market Woos Open Source

35. Pinnacle: IBM MXT in a Memory Controller Chip

36. SEMM-2: a new generation of single-event-effect modeling tools

37. The ultimate dielectric is... nothing: IBM packs wires in vacuum to speed chips and save power

38. Airtel and IBM complete first phase of Open Hybrid Cloud Network

39. IBM and AMD Announce Joint Development Agreement to Advance Confidential Computing for the Cloud and Accelerate Artificial Intelligence

40. United States : IBM and AMD Announce Joint Development Agreement to Advance Confidential Computing for the Cloud and Accelerate Artificial Intelligence

41. Biorasi selects IBM to expand clinical trial execution capabilities

42. Mateon is Selected by IBM Watson Health for the Use of IBM Clinical Development Solution at No Cost for Phase II Clinical Trial of OT-101 for COVID-19

43. MATEON IS SELECTED BY IBM WATSON HEALTH FOR THE USE OF IBM CLINICAL DEVELOPMENT SOLUTION AT NO COST FOR PHASE II CLINICAL TRIAL OF OT-101 FOR COVID-19

44. Mateon is Selected by IBM Watson Health for the Use of IBM Clinical Development Solution at No Cost for Phase II Clinical Trial of OT-101 for COVID-19

45. IBM Watson Health rolls out new clinical trial design software

46. IBM Study Advance Designed to Reduce the Time and Costs Associated with Clinical Trials

47. IBM Study Advance Designed to Reduce the Time and Costs Associated with Clinical Trials

48. IBM Study Advance Tool Aims to Reduce Cost and Time of Clinical Trials

49. IBM Study Advance Designed to Reduce the Time and Costs Associated with Clinical Trials

50. IBM Highlights Ballistic Nanowire Connections

Catalog

Books, media, physical & digital resources